CRISPR Therapeutics AG (CRSP) Ownership

$38.36

south_east
-$0.49 (-1.26%)
Day's range
$38.21
Day's range
$40.19

CRISPR Therapeutics AG Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
CAPITAL INTERNATIONAL INVESTORS 11/13/2024 7.93 M $372.40 M   0.78% 9.30%
ARK INVESTMENT MANAGEMENT LLC 10/31/2024 7.50 M $352.29 M   -3.60% 8.80%
STATE STREET CORP 11/14/2024 2.99 M $140.61 M   25.04% 3.51%
SUMITOMO MITSUI TRUST HOLDINGS, INC. 11/05/2024 2.97 M $139.44 M   -5.82% 3.48%
NIKKO ASSET MANAGEMENT AMERICAS, INC. 11/07/2024 2.97 M $139.37 M   -5.85% 3.48%
BLACKROCK FUNDING, INC. /DE 11/13/2024 2.80 M $131.32 M   100.00% 3.28%
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. 11/14/2024 2.74 M $128.61 M   0.25% 3.21%
FMR LLC 11/13/2024 2.38 M $111.63 M   0.98% 2.79%
VANGUARD GROUP INC 11/13/2024 1.73 M $81.06 M   -1.32% 2.02%
NEA MANAGEMENT COMPANY, LLC 11/14/2024 1.59 M $74.60 M   0.00% 1.86%
ECOR1 CAPITAL, LLC 11/14/2024 1.39 M $65.27 M   0.00% 1.63%
BANK OF AMERICA CORP /DE/ 11/14/2024 1.08 M $50.82 M   14.89% 1.27%
SR ONE CAPITAL MANAGEMENT, LP 11/13/2024 1.05 M $49.28 M   0.00% 1.23%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2024 1.01 M $47.38 M   3.62% 1.18%
LOOMIS SAYLES & CO L P 11/13/2024 945,267 $44.41 M   -6.06% 1.11%
BAKER BROS. ADVISORS LP 11/14/2024 843,075 $39.61 M   743.08% 0.99%
DIMENSIONAL FUND ADVISORS LP 11/07/2024 824,606 $38.74 M   -13.21% 0.97%
CONTRARIUS INVESTMENT MANAGEMENT LTD 11/08/2024 783,898 $36.83 M   14.32% 0.92%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/12/2024 724,241 $34.02 M   0.92% 0.85%
CITADEL ADVISORS LLC 11/14/2024 695,400 $32.67 M   -2.17% 0.82%
UBS GROUP AG 11/14/2024 673,588 $31.65 M   58.78% 0.79%
MORGAN STANLEY 11/14/2024 632,003 $29.69 M   5.74% 0.74%
BALYASNY ASSET MANAGEMENT L.P. 11/14/2024 623,650 $29.30 M   587.87% 0.73%
BELLEVUE GROUP AG 11/14/2024 610,000 $28.66 M   -1.24% 0.72%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2024 604,700 $28.41 M   25.87% 0.71%
CITADEL ADVISORS LLC 11/14/2024 518,547 $24.36 M   263.73% 0.61%
VERSANT VENTURE MANAGEMENT, LLC 11/08/2024 498,558 $23.42 M   0.00% 0.58%
BAILLIE GIFFORD & CO 11/05/2024 364,768 $17.14 M   -10.03% 0.43%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2024 358,903 $16.86 M   37.61% 0.42%
JPMORGAN CHASE & CO 12/26/2024 354,242 $16.64 M   7.65% 0.42%
CAPITAL ADVISORS INC/OK 10/28/2024 300,589 $14.12 M   8.12% 0.35%
CITADEL ADVISORS LLC 11/14/2024 280,000 $13.15 M   -24.53% 0.33%
TANG CAPITAL MANAGEMENT LLC 11/14/2024 266,500 $12.52 M   -15.80% 0.31%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2024 263,400 $12.37 M   -25.17% 0.31%
PICTET ASSET MANAGEMENT HOLDING SA 11/12/2024 250,290 $11.84 M   31.45% 0.29%
SQUAREPOINT OPS LLC 11/14/2024 248,979 $11.70 M   -7.38% 0.29%
RAFFERTY ASSET MANAGEMENT, LLC 11/13/2024 214,094 $10.06 M   17.27% 0.25%
GOLDMAN SACHS GROUP INC 11/14/2024 209,840 $9.86 M   -20.92% 0.25%
WELLS FARGO & COMPANY/MN 11/13/2024 203,029 $9.54 M   -10.80% 0.24%
ARMISTICE CAPITAL, LLC 11/14/2024 200,000 $9.40 M   0.83% 0.23%
EAGLE HEALTH INVESTMENTS LP 11/12/2024 197,000 $9.26 M   0.00% 0.23%
AMERIPRISE FINANCIAL INC 11/14/2024 186,761 $8.77 M   14.66% 0.22%
TWO SIGMA INVESTMENTS, LP 11/14/2024 179,053 $8.41 M   949.61% 0.21%
VESTMARK ADVISORY SOLUTIONS, INC. 11/14/2024 174,097 $8.18 M   -11.90% 0.20%
JANE STREET GROUP, LLC 11/15/2024 171,430 $8.05 M   -51.01% 0.20%
CAPITAL INTERNATIONAL SARL 11/13/2024 170,523 $8.01 M   14.14% 0.20%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 11/14/2024 166,263 $7.81 M   100.00% 0.20%
SPEAR HOLDINGS RSC LTD 10/17/2024 165,000 $7.75 M   0.00% 0.19%
TD ASSET MANAGEMENT INC 11/01/2024 159,644 $7.55 M   0.00% 0.19%
SWISS NATIONAL BANK 11/07/2024 157,600 $7.40 M   -0.69% 0.18%

CRISPR Therapeutics AGinstitutional Ownership - FAQ's

Who are the largest shareholders of CRSP shares?

During the previous two years, 557 institutional investors and hedge funds held shares of CRISPR Therapeutics AG. The most heavily invested institutionals were:

INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC: 0

Ridgewood Investments LLC: 0

Rise Advisors, LLC: 0

Miracle Mile Advisors, LLC: 0

Harbour Capital Advisors, LLC: 0

Capital International Investors: 7.93 M

What percentage of CRISPR Therapeutics AG stock is owned by institutional investors?

69.75% of CRISPR Therapeutics AG stock is owned by institutional investors.

How much institutional buying is happening at CRSP ?

Institutional investors have bought a total of 64.39 M shares in the last 24 months. This purchase volume represents approximately $2.47 B in transactions.